QuickView for quaternary ammonium group transmembrane transporter activity (biogroup)

1. Drug target sets for approved compounds
2. Lean and obese B6 and BTBR mice aged 4 weeks and 10 weeks
3. Non-alcoholic fatty liver, non-alcoholic steatohepatitis, and type 2 diabetes mellitus rats
4. Expression in hepatic cells expressing or not expressing Foxl1
5. Kidney and liver tumors arising from transient expression of stem cell reprogramming factors

There were no matches for quaternary ammonium group transmembrane transporter activity